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Metabolic syndromeAbstract Background: Abdominal obesity is a strong determinant of obesity related metabolic
complications. Data about pre-pubertal children are scarce.
The aim of this study is to assess the presence of insulin resistance using different insulin
sensitivity indices and investigate its relationship with abdominal fat distribution by Dual energy
X-ray absorptiometry scan (DXA). Secondary outcome is to determine the frequency of the meta-
bolic syndrome components.
Subjects and methods: Twenty-three pre-pubertal obese children were recruited (14 females, 9
males). Height, weight, body mass index (BMI), waist and hip circumferences, waist to hip ratio,
and blood pressure were measured. Fasting blood samples were withdrawn for glucose, insulin,
lipid proﬁle, thyroid and liver functions. Patients underwent oral glucose tolerance testing (OGTT)
and DXA scan for body composition. Insulin sensitivity was determined using homeostasis model
assessment for insulin resistance (HOMA-IR), fasting glucose to insulin ratio, Matsuda, and
Cederholm indices.
Results: All patients had BMI, waist circumference, and DXA trunk fat more than 2 SDS. Mean
fasting glucose, insulin, fasting glucose to insulin ratio, 120 min glucose and HOMA-IR were within
normal limits, but mean Matsuda and Cederholm indices exceeded cut off limits. Dyslipidaemia was
detected in 13 patients (56.5%), disturbed glucose homeostasis in 8 patients (34.8%), and systolicl.: +20
ussein),
250 H. Elsedfy et al.hypertension in 1 patient (4.3%). Metabolic syndrome diagnosis was established in three patients
(13%). More insulin resistant patients were detected by Matsuda index. Trunk fat SDS correlated
with Matsuda and Cederholm indices only.
Conclusion: Dysglycaemia and dyslipidaemia are common among pre-pubertal obese children.
Insulin sensitivity indices based on OGTT are superior to fasting indices in identifying at risk chil-
dren. OGTT should be included in assessing obese children with BMI > 2 SDS. DXA scanning has
limited value for this purpose in clinical settings.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
The prevalence of childhood obesity has considerably in-
creased in the Middle East and Eastern Europe [1]. Insulin
resistance is associated with adiposity in an ethnic dependant
fashion [2]. There is no universal agreement on the deﬁnition
of cardio-metabolic risk factors or elements of metabolic syn-
drome associating obesity in childhood in contrast to adults
[3]. Obesity as determined by body mass index (BMI) and/
or waist circumference (WC) has been proven to be closely
related to the occurrence of the metabolic syndrome and type
2 diabetes in later life. However, children remain under-repre-
sented in such studies [3]. BMI had been criticized in this
regard due to inability to differentiate between fat and fat-free
mass and direct measures of abdominal obesity such as waist
circumference and body fat mass by Dual energy X-ray
absorptiometry (DXA) scan had been proposed to be superior
to BMI in some studies [4]. DXA scan detects abdominal fat
accurately, and android fat distribution determined by it, is
associated with negative metabolic predictors in pubertal
adolescents and adults [5,6]. Accumulation of visceral fat
starts in childhood and thus early detection of at risk children
is important [7].
The aim of this study is to assess the presence of insulin
resistance using different insulin sensitivity indices in a sample
of pre-pubertal obese children, and to investigate the relation-
ship between insulin resistance and abdominal fat distribution
measured by DXA scan. Secondary outcome is to determine
the frequency of the components of the metabolic syndrome
in the same sample of patients.
2. Materials and methods
Twenty-three children (14 females and 9 males) were prospec-
tively recruited during the period from 1st May 2012 to 28th
November 2012. Obesity was deﬁned according to Cole et al.
in children with BMI > 95th percentile for age and sex [7].
Pubertal staging was deﬁned according to Tanner and White-
house [8]. Exclusion criteria included Tanner stage 2 or more,
patients with eating disorders, endocrine causes of obesity such
as hypothyroidism or Cushing, intake of steroid or anti-epilep-
tic medications, weight losing drugs, or patients currently en-
rolled in a weight losing program. All participants and their
guardians or parents signed an informed consent for participa-
tion in the study. The study protocol was approved by the local
ethics committee of Ain-Shams University. This work has been
carried out in accordance with the code of ethics of the World
Medical Association (Declaration of Helsinki) for experiments
involving humans.2.1. Anthropometric assessment
Standing height was measured without shoes, to the nearest
0.1 cm, using Harpenden stadiometer (Holtain ltd, Croswell,
Crymych, UK) and weight was measured using a digital scale,
to the nearest 0Æ1 kg, wearing light clothing and without shoes.
BMI was calculated using the formula kg/m2. Weight to height
ratio was calculated by dividing weight by height. Standard
deviation scores (SDS) for weight, height, weight to height ratio,
and BMI were calculated [7,8]. Waist and hip circumferences
were measured using a ﬂexible tape to the nearest 0.1 cm. Waist
circumference (WC) was measured at the end of expiration mid-
way between the lower ribmargin and the iliac crest, and hip cir-
cumference (HC)wasmeasured at the level of greater trochanter
[3]. Waist hip ratio (WHR) was calculated by dividing WC by
HC, and standard deviation scores forWC andWHRwere esti-
mated [9]. All measurements were taken twice. Blood pressure
wasmeasured by a standardmercury sphygmomanometer, after
the subject had rested for 5 min in the sitting position, using the
appropriate cuff size and the 5thKorotkoff sound was taken for
diastolic blood pressure categorization.
2.2. Laboratory assessment
All participants performed an oral glucose tolerance test
(OGTT) as follows: after a 12 h overnight fast, a venous cath-
eter was inserted in an ante-cubital vein; fasting blood sample
was withdrawn for estimation of fasting plasma insulin (FI),
and fasting blood glucose (FBG). The venous blood sample
was also analyzed for lipid proﬁle: total cholesterol (TC), tri-
glycerides (TG), low density lipoprotein (LDL), and high den-
sity lipoprotein-cholesterol (HDL), alanine transferase (ALT),
free thyroxine (FT4), and thyroid stimulating hormone (TSH).
Participants then ingested 1.75 mg/kg glucose (maximum
75 g), and blood samples were withdrawn again after 30, 60,
90 and 120 min for estimation of plasma insulin and blood glu-
cose. Blood glucose was measured using the glucose oxidase
method (Glucose & Lactate Analyzer 2300 Stat Plus; Yellow
Springs Instruments, Yellow Springs, OH). Insulin was
determined by commercially available radioimmunoassy kit
(Pharmacia Diagnostics, Uppsala, Sweden). A fasting glucose
P100 mg/dl was indicative of impaired fasting glucose, [10]
and 120 min blood glucose P140 mg/dl was indicative of im-
paired glucose tolerance [11]. Fasting glucose insulin ratio
was calculated by dividing fasting glucose by fasting insulin val-
ues. A ratio less than 5.6 was considered the cut off level for
insulin resistance [12]. Insulin sensitivity indices were calculated
as proposed by Matthews et al. for homeostasis model assess-
ment for insulin resistance (HOMA-IR), Matsuda and
Table 1 Anthropometric characteristics of the patients.
Total (n= 23) Females (n= 14) Males (n= 9)
Age (yrs) 9.0 (3.1) 8.4 (3.1) 9.8 (3.2)
Weight SDS 8.9 (5.2) 7.9 (6.1) 8.1 (7.1)
Wt: ht SDS 8.5 (4.6) 8.1 (4.5) 9.3 (5)
BMI SDS 3.6 (0.9) 3.6 (0.9) 3.6 (0.8)
WC SDS 7.2 (2.9) 7.6 (2.8) 6.6 (3.3)
WHR SDS 1.5 (1.3) 1.3 (1.4) 1.8 (1.3)
Data are presented as mean (SD).
Yrs: years, wt: weight, ht: height, BMI: body mass index, WC: waist
circumference, WHR: waist hip ratio, SDS: standard deviation
score.
Insulin resistance in obese pre-pubertal children 251DeFronzo (ISI Matsuda), and Cederholm andWibell (ISI Ced-
erholm) [13–15]. Cut off level for diagnosing insulin resistance/
impaired insulin sensitivity with HOMA-IR was >2.7 [12],
with ISI (Matsuda) was >5 and with ISI (Cederholm) >75
[16]. The diagnosis of metabolic syndrome was made using
the criteria proposed by the WHO for adolescents [17]: diagno-
sis was made in the presence of obesity (BMI > 95th percentile)
plus two or more of the following risk factors: Glucose Homeo-
stasis (pre-pubertal hyperinsulinaemia >15 mU/L, fasting glu-
cose P100 mg/dl and impaired glucose tolerance: 120 min
P140 mg/dl), elevated blood pressure (systolic blood pressure
(SBP) >95th percentile for age, sex and height), dyslipidaemia
(TG > 105 mg/dl for children <10 years and >136 mg/dl for
childrenP 10 years, HDL-Cholesterol <35 mg/dl) [18].
2.3. Dual energy X-ray absorptiometry (DXA)
Body composition was measured by DXA machine (GE Lunar
Prodigy, DPX; Lunar Corp, Madison, WI, USA). Body scans
were analyzed using software provided by the manufacturer
(enCORE software version 12.2). Scanning was done in 1 cm
slices from head to toe by using the 20-min scanning speed.
The whole body scan included total body and three regional
fat measures: trunk (chest, abdomen, and pelvis), arms, and
legs. The trunk region was delineated by an upper horizontal
border below the chin, vertical borders lateral to the ribs,
and a lower border formed by oblique lines passing through
the femoral necks. The leg region was deﬁned as the tissue be-
low the oblique lines passing through the femoral necks [19].
The android and gynoid abdominal fat distribution were cal-
culated using the provided software. Only the android region
was used in comparison because it was previously proved that
adults and adolescents with android fat distribution and excess
central abdominal fat have increased cardio-metabolic risk as
compared to subjects with gynoid fat distribution [5]. Android
fat >50%, central to peripheral fat% ratio >1, and trunk fat
SDS >2 were chosen as arbitrary cut-off limits to deﬁne high
abdominal fat mass.
2.4. Statistical analysis
The data were analyzed by SPSS statistical software (version
17.0, SPSS Inc., Chicago, IL, USA). Descriptive statistics are
expressed as mean and standard deviation (SD). Student’s t
test was performed for comparison between the mean values
of the different groups for parametric data. Mann–Whitney
test for non-parametric data was used. Pearson correlation
was used for correlation between different variables. For all
tests a probability (p) less than 0.05 was considered signiﬁcant.
3. Results
The mean (SD) age of the studied group was 9 (3.1) years
[range: 4.7–13.5 years]. All were of Tanner stage 1. Body mass
index SDS and waist circumference SDS were >2 in all pa-
tients. Waist to hip ratio SDS was >2 in 10 (43.5%) patients
(5 females (35.7%) and 5 males (55.5%)). Mean (SD) weight
SDS of the studied patients was 8.9 (5.2), BMI SDS was 3.6
(0.9), WC SDS was 7.2 (2.9), and WHR SDS was 1.5 (1.3).
The anthropometric data of the studied patients are shown
in Table 1. DXA scan showed that mean (SD) total bodyfat% was 46.5 (4.7), trunk fat SDS was 4.7 (2.1), android fat
percentage was 51.4 (5.7), and central: peripheral fat% ratio
was 0.92 (0.1), (Table 2).
The mean fasting glucose, 120 min glucose, fasting insulin,
fasting glucose to insulin ratio, and HOMA-IR were within
normal limits, but the mean ISI (Matsuda) and ISI (Ceder-
holm) exceeded the cut off limits. Mean fasting lipid proﬁle,
thyroid function, and ALT values were within normal range
(Table 3).
No signiﬁcant difference was found between males and
females in anthropometric measures, DXA measures, or labo-
ratory parameters. (p> 0.05).
The frequency of patients exceeding the cut off limits for
each insulin sensitivity index is presented in Table 4. The big-
gest number was detected using the Matsuda index (21/23,
91%) followed by HOMA-IR (7/23, 30.4%), then Cederholm
index (4/23, 17.4%), and lastly FGIR (2/23, 8.7%). Two pa-
tients (8.7%) were insulin resistant on all three insulin sensitiv-
ity indices [HOMA-IR, ISI (Matsuda), ISI (Cederholm)].
Dyslipidaemia (abnormal TG or HDL) was detected in 13 pa-
tients (56.5%): 9 had low HDL, and 4 had high TG. Eight pa-
tients had disturbed glucose homeostasis (34.8%) as previously
described in the methodology for the diagnosis of metabolic
syndrome. Only one patient (4.3%) had systolic hypertension.
The diagnosis of metabolic syndrome was established in three
patients (13%) (Table 4).
All patients had trunk fat SDS > 2 while only 13 patients
(56.5%) had android fat more than 50% while central to
peripheral fat% ratio was more than one in three patients
(13%). No signiﬁcant difference was noted between males
and females (p> 0.05), (Table 4). In patients with android
fat > 50%, 2 (2/13, 15.4%) had disturbed glucose homeosta-
sis, one (7.7%) was insulin resistant by all three insulin sensi-
tivity indices, and 7 (7/13, 53.8%) showed dyslipidaemia.
A negative correlation was found between trunk fat SDS
and insulin sensitivity measured by both ISI (Matsuda) and
ISI (Cederholm) but not with HOMA-IR, fasting glucose, fast-
ing insulin, or fasting glucose insulin ratio. Trunk fat SDS did
not correlate with triglycerides or HDL-Cholesterol. Neither
android fat nor central to peripheral fat ratio correlated with
any of the lipid parameters, glucose homeostasis measures or
insulin sensitivity indices, (Table 5).
4. Discussion
The most striking ﬁnding in this study is the relatively large
percentage of children found to have disturbed glucose and
Table 4 Number and frequency of patients above cut off limits for disturbed lipid, and glucose homeostasis.
Total (n= 23) n (%) Females (n= 14) n (%) Males (n= 9) n (%)
HDL< 35 mg/dl 9 (39.1) 4 (28.6) 5 (55.5)
TG> 105 (<10 yrs),>136 (>10 yrs) mg/dl 4 (17.4) 2 (14.3) 2 (22.2)
Fasting insulin > 15 mU/L 5 (21.7) 3 (21.4) 2 (22.2)
IFGP 100 mg/dl 4 (17.4) 2 (14.3) 2 (22.2)
IGT@ 120 minP 140 mg/dl 2 (8.7) 1 (7.1) 1 (11.1)
HOMA-IR> 2.7 7 (30.4) 5 (35.7) 2 (22.2)
FGIR< 5.6 2 (8.7) 2 (14.3) 0 (0)
ISI (Matsuda) > 5 21 (91) 13 (92.9) 8 (88.9)
ISI (Cederholm) > 75 4 (17.4) 2 (14.3) 2 (22.2)
Android fat > 50% 13 (56.5) 8 (57.1) 5 (55.5)
Central: peripheral fat%> 1 3 (13) 2 (14.3) 1 (11.1)
Trunk fat > 2 SDS 23 (100) 14 (100) 9 (100)
Systolic BPP 95th centile 1 (4.3) 0 (0) 1 (11.1)
Diastolic BPP 95th centile 0 (0) 0 (0) 0 (0)
HDL: high density lipoprotein, TG: triglycerides, IFG: impaired fasting glucose, IGT: impaired glucose tolerance, HOMA-IR: homeostasis
model assessment for insulin resistance, FGIR: fasting glucose insulin ratio, SDS: standard deviation score, BP: blood pressure.
Table 3 Biochemical proﬁle of the studied patients.
Total (n= 23) Females (n= 14) Males (n= 9)
TC (mg/dl) 161.3 (40) 169.2 (44.6) 149 (29.1)
HDL (mg/dl) 44.8 (18.9) 47.6 (18.5) 40.1 (19.8)
LDL (mg/dl) 91.7 (30.6) 98 (32.5) 81.9 (26.2)
TG (mg/dl) 95.1 (29.8) 88.9 (31.6) 104.8 (24.5)
ALT (U/L) 17.2 (2.2) 17.4 (1.9) 16.8 (2.6)
FT4 (ng/dl) 1.1 (0.2) 1.2 (0.2) 1.1 (0.2)
TSH (mIU/L) 2.5 (1) 2.8 (1.1) 2.1 (0.8)
FBG (mg/dl) 90.4 (11.8) 88 (12.3) 94.9 (10.2)
Glucose 60 min (mg/dl) 138 (32) 141.3 (33.7) 131.9 (30)
Glucose 120 min (mg/dl) 107.6 (21.3) 105.8 (19.1) 111 (26.4)
Fasting insulin (lU/ml) 10.5 (4.3) 10.4 (4.2) 10.7 (5)
Insulin 60 min (lU/ml) 87.5 (73.2) 77.4 (42) 106.9 (113)
Insulin 120 min (lU/ml) 65.5 (52.1) 58.2 (26.6) 78.8.3 (83)
FGIR 10.8 (5.8) 9.7 (4) 12.8 (8.2)
HOMA-IR 2.4 (1.2) 2.3 (1) 2.6 (1.4)
ISI (Matsuda) 9.8 (4.7) 9.5 (3.9) 10.3 (6.1)
ISI (Cederholm) 59.3 (18.8) 57.6 (15.5) 62.3 (25)
Data are presented as mean (SD).
TC: total cholesterol, HDL: high density lipoprotein, LDL: low density lipoprotein, TG: triglycerides, ALT: alanine transferase, FT4: free
thyroxine, TSH: thyroid stimulating hormone, FBG: fasting blood glucose, FGIR: fasting glucose insulin ratio, HOMA-IR: homeostasis model
assessment for insulin resistance, ISI (Matsuda): insulin sensitivity index by Matsuda and De Fronzo, 1999, ISI (Cederholm): insulin sensitivity
index by Cederholm and Wibell, 1990, min: minutes during oral glucose tolerance test.
Table 2 DXA scan data of the studied patients.
Total (n= 23) Females (n= 14) Males (n= 9)
Total body fat% 46.5 (4.7) 47.1 (4.7) 45.5 (5.1)
Trunk fat (kg) 12.8 (4.6) 11.9 (4) 14.2 (5.4)
Trunk fat SDS 4.7 (2.1) 4.2 (1.7) 5.6 (2.5)
Trunk fat% 46.4 (4.2) 46.9 (4.2) 45.5 (4.4)
Android fat% 51.4 (5.7) 52 (5.9) 50.5 (5.6)
Gynoid % 51 (4.2) 52.2 (3.6) 49.3 (4.7)
Central: peripheral fat% ratio 0.92 (0.1) 0.9 (0.1) 0.9 (0.1)
Leg Fat (kg) 10.8 (3.8) 10.3 (3.7) 11.5 (4.3)
Leg fat% 48 (5.2) 48.9 (4.6) 46.6 (6.1)
Leg fat SDS 3.8 (1.9) 4.4 (2.2) 3.5 (1.8)
Data are presented as mean (SD).
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Table 5 Correlation between insulin sensitivity and DXA indices of adiposity.
FBG FI FGIR HOMA-IR ISI (Matsuda) ISI (Cederholm)
Trunk fat SDS r= 0.173 r= 0.397 r= 0.130 r= 0.421 r= 0.524 r= 0.562
p= 0.508 p= 0.114 p= 0.619 p= 0.093 p= 0.03* p= 0.018*
Central: peripheral fat% r= 0.106 r= 0.170 r= 0.317 r= 0.171 r= 0.359 r= 0.250
p= 0.684 p= 0.515 p= 0.216 p= 0.512 p= 0.157 p= 0.333
Android fat r= 0.223 r= 0.081 r= 0.419 r= 0.011 r= 0.151 r= 0.324
p= 0.390 p= 0.757 p= 0.094 p= 0.966 p= 0.564 p= 0.205
FBG: fasting blood glucose, FI: fasting insulin, FGIR: fasting glucose insulin ratio, HOMA-IR: homeostasis model assessment for insulin
resistance, ISI (Matsuda): insulin sensitivity index by Matsuda and De Fronzo, 1999, ISI (Cederholm): insulin sensitivity index by Cederholm
and Wibell, 1990, SDS: standard deviation score.
* Statistically signiﬁcant. p< 0.05 is clinically signiﬁcant.
Insulin resistance in obese pre-pubertal children 253lipid metabolism. More than one third and more than half had
disturbed glucose and lipid homeostasis respectively. This indi-
cates the severity of the problem among the population. It has
been suggested that ethnic differences play a role in the preva-
lence of obesity related cardio-metabolic complications. Most
studies focused on Caucasian, African-American, and Asian
populations [20]. Further, most studies were carried on puber-
tal children [21]. To the best of our knowledge, there is paucity
in the literature regarding the prevalence of obesity related
metabolic complications in obese pre-pubertal children in the
region of the Middle East and North Africa. Recent reports
show that the Middle East and North Africa have the highest
obesity and diabetes prevalence among young adults [22].
The overall prevalence rate of metabolic syndrome is 3–4%,
with a wide variation in the reported rates among children and
adolescents ranging from 1.7% to 14% [18,23–31]. The rate
found in our sample (13%) is thus comparable with some of
the reported rates, and in view of the limited number of the
studied patients, such rate provides a warning sign to the ex-
tent of the problem among Egyptian children which possibly
outweighs that reported for other ethnic populations. In a
study conducted on Egyptian adolescents, the prevalence of
metabolic syndrome was 7.4% [25].
The lack of a uniform deﬁnition for metabolic syndrome in
pediatrics in the literature [32], the fact that its risk increases
with every 0.5 unit increment in BMI, the ﬁnding that the prev-
alence of impaired fasting serum glucose and insulin and im-
paired glucose tolerance increase signiﬁcantly with BMI > 2
SDS [26], were the reasons to choose all our patients with
BMI > 2 SDS and not only BMI > 95th percentile. Not every
obese patient with BMI > 95th percentile will have BMI > 2
SDS. Furthermore, all had waist circumference >2 SDS, a
cut off value that ensures that all studied patients had WC
values above the 90th percentile. Waist circumference is an
indirect measure of visceral fat and a predictor of cardio-met-
abolic risk in obese children [32]. Thus combining BMI and
waist circumference cut offs >2 SDS would ensure that the
studied patients are at especially high risk of obesity related
cardio-metabolic complications [25,32].
A signiﬁcant proportion of the patients were found to be
insulin resistant using different insulin sensitivity indices. The
biggest number was detected using the insulin sensitivity index
developed by Matsuda which reﬂects whole body insulin sensi-
tivity, followed by HOMA-IR (reﬂects basal hepatic glucose
production and hepatic insulin sensitivity). Insulin sensitivityindex introduced by Cederholm and Wibell reﬂecting periphe-
ral insulin sensitivity and muscular glucose uptake identiﬁed
insulin resistance in 17.4% of our patients while fasting glu-
cose insulin ratio identiﬁed the least number of patients. How-
ever, only a small number proved to be insulin resistant on the
three insulin sensitivity indices together. This suggests the
inadequacy of any of the individual insulin sensitivity indices
proposed in the literature. They are however important as pre-
dictors of impaired insulin sensitivity which commonly precede
the development of type 2 diabetes [33]. da Silva et al. showed
that the likelihood of metabolic syndrome increases with high
insulin and HOMA-IR [34]. HOMA-IR >2.5 increased the
prevalence of metabolic syndrome from 7.4% to 35.9% [25],
and HOMA-IR was more reliable than FGIR when both were
compared to OGTT in obese pubertal adolescents [35]. How-
ever, indices based on OGTT including Matsuda index were
found superior to HOMA-IR in predicting insulin sensitivity
[36]. While OGTT derived tests consider glucose–insulin inter-
actions that occur in vivo after glucose load [37], HOMA-IR
and other tests based on fasting samples do not take into ac-
count the peripheral insulin sensitivity. They assess hepatic
insulin action only which is reﬂected by the early glucose
response and correlates with fasting glucose [37,38]. OGTT
derived indices could detect ‘‘subtle changes’’ in glucose
metabolism that are not detected by the simpler fasting indices
[39]. Many studies demonstrated a stronger correlation of insu-
lin sensitivity indices derived from glucose tolerance test with
the golden reference techniques such as hyperinsulinaemic
euglycaemic clamp, and hence more reliability of these indices
than simple fasting indices for insulin sensitivity [37]. This con-
ﬁrms the ﬁndings of this study.
Despite the fact that all patients had trunk fat SDS > 2,
only 56.6% had excess android fat deﬁned by our arbitrary
cut off. This cut off identiﬁed less number of patients with
disturbed glucose homeostasis, insulin resistance, and dyslip-
idaemia compared to trunk fat SDS > 2. We therefore recom-
mend that it would be inappropriate to use such a cut off
particularly in children before puberty.
No correlation existed between trunk fat and fasting glu-
cose, insulin, and lipids. He et al. previously reported a positive
correlation between trunk fat and insulin and triglycerides [6].
The correlation found in our sample between trunk fat and
insulin sensitivity indices based on the standard oral glucose
tolerance test (ISI Matsuda and Cederholm) and the lack of
correlation between it and indices depending on fasting
254 H. Elsedfy et al.samples (HOMA-IR, FGIR) suggest the superiority of OGTT
in this young age group. It would thus be more appropriate to
perform OGTT in obese children with BMI SDS > 2 in order
to detect those at risk for type 2 diabetes. This would deﬁnitely
allow early intervention and prevention of future adverse met-
abolic complications. It was previously reported that children
with normal HOMA-IR and fasting insulin were found to have
insulin resistance on OGTT thereby conﬁrming the need to
perform OGTT in such patients [40].
Android fat distribution was not beneﬁcial in identifying
high risk obese children. All patients with BMI SDS and waist
circumference SDS exceeding two had trunk fat SDS > 2. We
therefore believe that body composition by DXA does not of-
fer extra information and that there is no need to use DXA
scan to identify obese children with obesity related metabolic
complications in clinical settings. DXA scan remains unable
to differentiate between subcutaneous and visceral fat and
therefore suitable only for research settings [32].
We believe that the main limitation of this study is the small
sample size. Despite this, a signiﬁcant number of children were
identiﬁed with insulin resistance emphasizing the need to carry
larger studies on this high risk population.
In conclusion, we believe that the ﬁndings of this study
should be taken as a warning sign and drive further studies
on a large population of obese pre-pubertal children. Although
the diagnosis of the metabolic syndrome was established in a
small percentage of patients, its components were identiﬁed
in a considerable number of them. This conﬁrms that disturbed
glucose and lipid homeostasis start early in obese subjects and
therefore increase the likelihood of type 2 diabetes and cardio-
vascular disease at a young age. Further, oral glucose tolerance
test should be included as part of the formal assessment of chil-
dren with BMI > 2 SDS. Lastly, assessment of body composi-
tion by DXA scan should be limited to research settings as it
does not seem to offer extra or early information regarding
the obesity related metabolic adverse effects.
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